Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cognitive Impairment Associated With Schizophrenia (CIAS)”

11 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 11 of 11 results

Testing effectiveness (Phase 2)Ended earlyNCT05182476
What this trial is testing

Study to Evaluate the Efficacy, Safety, and Tolerability of Luvadaxistat in Participants With Cognitive Impairment Associated With Schizophrenia

Who this might be right for
Schizophrenia
Neurocrine Biosciences 216
Not applicableStudy completedNCT07446478
What this trial is testing

TIS for Improving Cognitive Impairment Associated With Schizophrenia

Who this might be right for
Cognitive Impairment Associated With Schizophrenia (CIAS)
Central South University 10
Testing effectiveness (Phase 2)Looking for participantsNCT07191483
What this trial is testing

Evaluate KYN-5356 in Adults With Cognitive Impairment Associated With Schizophrenia

Who this might be right for
Cognitive Impairment Associated With Schizophrenia (CIAS)
Kynexis B.V. 150
Testing effectiveness (Phase 2)Study completedNCT05686239
What this trial is testing

Evaluate RL-007 in the Treatment of Cognitive Impairment Associated With Schizophrenia (CIAS)

Who this might be right for
Cognitive Impairment Associated With Schizophrenia (CIAS)Cognitive ImpairmentSchizophrenia
Recognify Life Sciences 242
Early research (Phase 1)Study completedNCT02228395
What this trial is testing

Study To Evaluate The Safety, Tolerability And Pharmacokinetics Of Single Doses Of PF-04958242 In Healthy Volunteers

Who this might be right for
Healthy
Biogen 12
Testing effectiveness (Phase 2)Study completedNCT02953639
What this trial is testing

Evaluate the Effects of Basmisanil in Participants With Cognitive Impairment Associated With Schizophrenia (CIAS) Treated With Antipsychotics

Who this might be right for
Schizophrenia
Hoffmann-La Roche 214
Testing effectiveness (Phase 2)Ended earlyNCT02855411
What this trial is testing

Evaluate The Safety And Efficacy Of PF-04958242 In Subjects With Cognitive Impairment Associated With Schizophrenia (CIAS)

Who this might be right for
Cognitive Impairment Associated With Schizophrenia (CIAS)
Biogen 35
Testing effectiveness (Phase 2)Study completedNCT03745820
What this trial is testing

Evaluate the Safety and Efficacy of BIIB104 in Participants With Cognitive Impairment Associated With Schizophrenia (CIAS)

Who this might be right for
Cognitive Impairment Associated With Schizophrenia
Biogen 195
Early research (Phase 1)Study completedNCT02332798
What this trial is testing

Multiple Ascending Doses of PF-04958242 in Subjects With Stable Schizophrenia

Who this might be right for
Schizophrenia
Biogen 39
Testing effectiveness (Phase 2)Study completedNCT01266174
What this trial is testing

Effects of Eltoprazine on Cognitive Impairment Associated With Schizophrenia (CIAS) in Adults

Who this might be right for
Cognitive ImpairmentSchizophrenia
Amarantus BioScience Holdings, Inc. 31
Early research (Phase 1)Study completedNCT04972227
What this trial is testing

Study to Assess the Safety and Pharmacokinetics of CY6463 in Participants With Stable Schizophrenia

Who this might be right for
Schizophrenia
Tisento Therapeutics 48